By Vishal Sridhar
(Reuters) - Indian shares rose more than 1 percent on Thursday after seven consecutive sessions of declines, as market heavyweights such as Infosys recovered and as drug maker Cipla gained on solid earnings.
The BSE Sensex and NSE Nifty shed nearly 6 percent each in the previous seven sessions, matching a losing streak of the same duration in September.
Thursday's gains came even as Asian shares flirted with six-week lows. MSCI's broadest index of Asia-Pacific shares outside Japan was little changed as U.S. bond yields crept up towards four-year highs.
Analysts said they expected global markets to stabilise, but said caution would remain in India amid continued worries that accelerating inflation would force the Reserve Bank of India to raise interest rates.
The RBI on Wednesday held rates steady and kept its policy stance at "neutral", with analysts saying the central bank's future action would depend on inflation.
"Market is into a trading zone with a broad-based recovery. The worst, as far as downside concerns and short-selling, is more or less done. But at the same time, the markets are not in clear waters yet with concerns over inflation," said Dharmesh Kant, an independent market expert.
The broader Nifty was up 1.21 percent at 10,603.85 as of 0541 GMT, while the benchmark Sensex was 1.31 percent higher at 34,529.79.
Pharma and realty stocks gained with the Nifty Pharma index and the Nifty Realty index climbing over 2.5 percent each.
Shares of Cipla surged as much as 6.85 percent after the country's fourth-largest drugmaker by revenue reported a 7 percent jump in quarterly profit on Wednesday.
IT service exporters Infosys and Tata Consultancy Services Ltd climbed over 3 percent and 2 percent, respectively.
(Reporting by Vishal Sridhar in Bengaluru; Editing by Subhranshu Sahu)
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
